Jubilant HollisterStier Receives Zero Observations from Recent U.S. Food and Drug Administration Inspection
SPOKANE, WA. – Jubilant HollisterStier, a sterile fill-finish and injectable pharmaceutical contract manufacturing organization, announces that a United States Food and Drug Administration (USFDA) inspection, performed by the Center for Biologics Evaluation and...
Jubilant HollisterStier Celebrates the Opening of Their Third Manufacturing Line with a Ribbon Cutting Ceremony
02.09.2024, Spokane, WA – Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line and the groundbreaking of the next phase of their facility expansion. JHS President and CEO...
Ian Fuller Named Vice President of Operations at Jubilant HollisterStier Contract Manufacturing
09.14.2023, Spokane, WA: Jubilant HollisterStier Contract Manufacturing is pleased to announce the appointment of Ian Fuller as the new Vice President of Operations. With over 25 years of progressive management experience in the biotech and pharmaceutical industries,...
Jubilant HollisterStier Announces CAD 100Mn Expansion of its CMO Manufacturing Facility at Montreal, Canada and Government of Quebec Funding of CAD 25Mn through a Loan
06.30.2022, Noida, India: Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Pharma Limited, through one of its wholly owned subsidiaries, Jubilant HollisterStier General Partnership, (JHS)a leading Canada-based pharmaceutical contract manufacturer,...
Jubilant HollisterStier LLC Enters into Cooperative Agreement of $149.6Mn with US Government to Expand Critical Vaccine Manufacturing Capacity
05.28.2022, Nabia, India: Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of the company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract...
Jubilant HollisterStier Receives Five CMO Leadership Awards 2022
03.16.2022, Spokane, WA & Montreal, CA: Jubilant HollisterStier LLC, a leading pharmaceutical contract manufacturer and a subsidiary of Jubilant Pharma Limited, today announced that it has received the prestigious CMO Leadership Awards 2022 in five categories -...
Jubilant HollisterStier to Host Groundbreaking Ceremony for $92 Million Expansion
11.11.2021, Noida, India: Jubilant HollisterStier LLC, a pharmaceutical contract manufacturer that is part of Jubilant Pharma Limited, announced plans to host a groundbreaking ceremony on Wednesday, November 17, 2021 at 11:00am PT at their Spokane, Washington...
Ocugen Secures Manufacturing Partnership for US Production of COVID-19 Vaccine Candidate, COVAXIN®
06.15.2021, Malvern, PA: Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it has...
Jubilant HollisterStier Announces $92Mn Expansion for Sterile Injectable Manufacturing Capacity
06.03.2021, Spokane, WA: Jubilant HollisterStier, a wholly owned subsidiary of ultimate parent company Jubilant Pharmova Limited, announces $92M investment to expand sterile injectable manufacturing capacity at its site in Spokane, WA. This investment is being made...
Elevating Your Vision with Personalized Support
Contact us today and let’s explore how we can support your next project.